Skip to main content
Equibles

Connor, Clark & Lunn Investment Management Ltd.

Position in CSTL — Castle Biosciences Inc

CIK 1596800 VANCOUVER, A1
Back to CSTL Full portfolio

Position in CSTL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,911,688
-$1,345,675 QoQ
Shares Held
331,727
-12.0% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#20
of 176 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CSTL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $189,818,037 across 16 Diagnostics & Research names. CSTL ranks #8 (4.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MEDP
Medpace Holdings, Inc.
 110,353 $58,441,845
2 GH
Guardant Health, Inc.
 215,395 $32,315,711
3 DHR
Danaher Corp /De/
 114,010 $21,716,624
4 TMO
Thermo Fisher Scientific Inc.
 36,269 $18,183,825
5 NEO
Neogenomics Inc
 802,597 $11,709,889
6 RVTY
Revvity, Inc.
 87,145 $9,695,752
7 MYGN
Myriad Genetics Inc
 1,407,860 $8,038,880
8 CSTL
Castle Biosciences Inc
This page 		331,727 $7,911,688

All Filings in CSTL

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,911,688 331,727
2026-03-31 $9,257,363 377,082
2025-12-31 $15,112,299 388,491
2025-09-30 $7,648,238 335,891
2025-06-30 $2,581,721 126,431
2025-03-31 $3,541,317 176,889
2024-12-31 $4,496,201 168,713
2024-09-30 $4,718,862 165,458
2024-06-30 $1,456,129 66,887
2024-03-31 $1,720,102 77,657
2023-12-31 $1,911,340 88,570
2023-09-30 $1,361,080 80,585
2023-06-30 $844,397 61,545
2023-03-31 $958,375 42,182
2022-12-31 $662,509 28,144
2022-09-30 $602,213 23,091
2022-06-30 $427,212 19,463